KATIE ALLEN: Open Payments
NPI 1235737982 · WAYNESVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $139 |
| Novo Nordisk Inc | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Insulet Corporation | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: Xeomin, Wegovy, REXULTI, ZORYVE, Rybelsus, Omnipod, Dexcom G6 Transmitter, Ozempic.
Industry payments across MO — which companies pay providers there.
